Description
USAGE AND SERVING SIZE
Serving Size
Age 4 to 9 years: 1 capsule daily
Age 10 years and older: 2 capsules daily, or as directed by a health care professional.
Please consult your physician before administering the first dose.
Warning
If you are pregnant, nursing or taking any medications, consult your doctor before first use. Discontinue use and consult your doctor if any adverse reactions occur.
Manufactured in a facility which processes Milk, Eggs, Fish, Shellfish, Tree Nuts, Peanuts, Wheat, Soybeans, and Sesame.
Safety
MVW Complete Probiotic Formulation Dietary Supplements are safety sealed for your protection. If the inner safety seal is broken or missing, do not use and contact MVW Nutritionals immediately at 1-855-236-8584.
Keep out of reach of children. Use caution when administering to children or individuals who have difficulty swallowing capsules.
To report a serious adverse event, please contact MVW Nutritionals immediately at 1-855-236-8584.
Contraindications
Do not use this product if you have a known sensitivity or allergy to any of the ingredients.
How Supplied
Bottles of 60 capsules
Storage
Store at room temperature in a dry place away from direct sunlight.
Are the MVW vitamins available through any special programs?
Yes, they are available through the AbbVie Care Forward program
(https://www.creon.com/CFPatients/CFCareForward)
and the Live2Thrive program
(https://www.live2thrive.org).
Ask about other program availability.
Are they available through my Specialty Pharmacy?
Our complete line of products are stocked by most of the Specialty Pharmacies across the country.
How are local pharmacists getting MVW Complete Formulation products through their wholesalers?
The Order Entry Numbers for MVW Nutritional Multivitamins – chewables, standard softgels, chewables and softgels with higher D, and drops are reflected in the chart below:
- Advise the pharmacist that the three major wholesalers – McKesson, ABC and Cardinal – have assigned order entry numbers for products that may be ordered through their respective wholesale distribution centers.
- The pharmacist should enter the number in their order entry system. If their local distribution center has already stocked the desired product, the order will process and product will arrive at to the pharmacist with the next shipment from the wholesaler – normally one to two days.
- If the local distribution center has never stocked the product, the order entry system will display one of two error messages: product discontinued, manufacturer backorder. Should the pharmacist get either of these two messages, they must CALL their local distribution center, provide the item number, and request that they stock the product. Distributors call this “activating an item” or “bringing the item in”. NOTE: Only an item with an assigned order entry can be activated at the local distribution center level in this manner.
- For products without an item number, the local distribution center must call their corporate office, and request that corporate assign an item number.
- If the pharmacist is (i) less than co-operative, or (ii) has questions, please call our toll-free number – 855-236-8584 – and we be happy to assist in this process.
LEARN MORE
REFERENCES
- Weiss B, Bujanover Y, Yahav Y, et al. Probiotic Supplementation Affects Pulmonary Exacerbations in Patients With Cystic Fibrosis: A Pilot Study. Pediatric Pulmonology. 2010;45:536-540.
- Rogers GB, Carroll M, Hoffman L, et al. Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes. 2008;1:85-93.
- Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics. 2008;28:385-396.
- Chmielewska A and Szajewska. Systematic review of randomized controlled trials: probiotics for functional constipation. World Journal of Gastroenterology. 2010;16:69-75.
- Quigley, EMM. The enteric microbiota in the pathogenesis and management of constipation. Best Practice and Research Clinical Gastroenterology. 2011;25:119-126.
- Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology. 2016;22:2219-2241.
- Di Nardo G, Oliva S, Menichella A, et al. Lactobacillus reuteri ATCC55730 in Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 2014;58:81-86.
- Gillanders L, Elborn J, Gilpin D, et al. The airway microbiome in cystic fibrosis: Challenges for therapy. 2011;8:645-660.
- Ojetti V, Ianiro G, Tortora A, et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. Journal of Gastrointestinal Liver Disease. 2014;23:387-391.
- Infante P, Redecillas F, Torrent V, et al. Improvement of intestinal function in cystic fibrosis patients using probiotics. Anales Pediatria. 2008;69:501-505.
- http://www.sciencedirect.com/science/article/pii/S1569199314000472
- http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2004.02174.x/full
- http://onlinelibrary.wiley.com/doi/10.1002/ppul.21138/epdf
- http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087796
Reviews
There are no reviews yet.